Delivery Order SPE2DB22D3301-SPE2DB24FY2ST

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,119.42 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a completion date of December 20, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp (a major pharmaceutical distributor) is a delivery order under a $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the medical product "OMNIPAQUE 350 MG/ML PLUSPAK 500ML" and has a ceiling value of $3,498.20. The contract is a Firm Fixed Price arrangement with an ultimate completion date of October 29, 2024. This contract does not have a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the medical product "OMNIPAQUE 350 MG/ML PLUSPAK 500ML" and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price of $1,690.80 and a period of performance through January 14, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $3,498.20, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product, to DLA facilities supporting the Department of Defense (DoD) worldwide. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, valued at $1,690.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through January 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OMNIPAQUE 240 MG/ML VIAL 10ML. The $1,736.57 firm fixed-price delivery order is not designated as a set-aside and has an ultimate completion date of November 30, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,307.00 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML intravenous infusion bottles, 100 mL in size. The contract has an ultimate completion date of September 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,513.00 firm fixed-price delivery order covers the supply of OMNIPAQUE 350 MG/ML INFU BTL 100ML, a specialty pharmaceutical product. The contract has a completion date of June 27, 2023 and is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FY2ST
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a for-profit pharmaceutical distribution company. The award, valued at $3,498.20, is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a specialty pharmaceutical product, to DLA Troop Support Medical facilities that support the Department of Defense.

The contract is a firm fixed price delivery order with a completion date of March 19, 2024. It is not associated with a larger contract vehicle and was awarded solely to AmerisourceBergen Drug Corporation as a single-award, indefinite delivery contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary means for AmerisourceBergen to provide a wide range of pharmaceutical products and medical supplies to DLA Troop Support Medical programs. No set-aside designation was used for this award.

Generated 6/17/24, 9:31 AM